Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor Following Failure of Prior Tyrosine Kinase Inhibitor Therapy
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009654/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy and safety of ponatinib in participants
with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure
of prior tyrosine kinase inhibitor (TKI) therapy.
提供机构：
Vivli
创建时间：
2023-12-21
